Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The relevance of these findings to humans is still under investigation
Side Effects Comparison# Retatrutide Side Effects# Phase 2 data (n=338 obesity trial): Nausea : ~25% at higher doses (8-12 mg) Diarrhea : ~20% Vomiting : ~15% Constipation : Common Decreased appetite : Common (pharmacological effect) Heart rate : Small increase (2-4 bpm), potentially related to glucagon component Injection site reactions : Mild, transient Discontinuation rate : 6-10% due to adverse events The glucagon receptor component introduces theoretical concerns for hyperglycemia (counterbalanced by GLP-1/GIP in practice), cardiovascular effects (chronotropic glucagon action), and hepatic effects, none of which produced safety signals in Phase 2 but require larger-scale monitoring
When you are eating less, every bite needs to count
BrightMeds has the highest Trustpilot rating (4.8/5 vs
Continue Retatrutide Titration (Weeks 512) With MOTS-c running, retatrutide titration continues based on tolerance
Diarrhea: Large amounts of undigested fats can irritate the digestive tract and cause diarrhea
